VPHOP (IP)
Osteoporotic Virtual Physiological Human (VPHOP)

(Scientific Coordinator)
Medical Technology Laboratory, Istituto di Ricerca Codivilla-Putti, Istituti Ortopedici Rizzoli,
via di Barbiano, 1/10
40136 Bologna, Italy
VPHOP participants
- SCS SRL
- Société d’Etudes et de Recherches de l’Ecole Nationale Supérieure d’Arts et Métiers
- Universität Bern
- Biospace Med SA
- University of Bedfordshire
- Technische Universiteit Eindhoven
- Philips Medical Systems Nederland BV
- empirica Gesellschaft für Kommunikations- und Technologieforschung mbH
- Université de Genève (UNIGE)
- Sylvia Lawry Centre for Multiple Sclerosis Research e.V.
- ANSYS France SAS
- Háskóli Íslands
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Uppsala universitet
- Charité - Universitätsmedizin Berlin
- Eidgenössische Technische Hochschule Zürich (ETHZ)
- BrainLAB AG
- Katholieke Universiteit Leuven
The aim of VPHOP is to develop a multiscale modelling technology based on conventional diagnostic imaging methods that makes it possible, in a clinical setting, to predict for each patient the strength of his/her bones, how this strength is likely to change over time, and the probability that the he/she will overload his/her bones during daily life. With these three predictions, the evaluation of the absolute risk of bone fracture will be much more accurate than any prediction based on external and indirect determinants, as it is current clinical practice.
These predictions will be used to:
- improve the diagnostic accuracy of the current clinical standards;
- to provide the basis for an evidence-based prognosis with respect to the natural evolution of the disease, to pharmacological treatments, and/or to preventive interventional treatments aimed to selectively strengthen particularly weak regions of the skeleton.
For patients at high risk of fracture, and for which the pharmacological treatment appears insufficient, the VPHOP system will also assist the interventional radiologist in planning the augmentation procedure. The various modelling technologies developed during the project will be validated not only in vitro, on animal models, or against retrospective clinical outcomes, but will also be assessed in term of clinical impact and safety on small cohorts of patients enrolled at four different clinical institutions, providing the factual basis for effective clinical and industrial exploitations.
|
Project details |
| Project Acronym: VPHOP Start Date: August, 2008 Duration: 4 years Project Cost: €12.073.349 Contract Type: Collaborative project (generic) End Date: August, 2012 Project Status: In progress Project Funding: €8.989.363 |
For more information on VPHOP click here
VPH Projects